Market Research Logo

Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review

Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholitin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Sopharma AD Key Recent Developments

Oct 26,2017: Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Sopharma AD - Key Facts
Sopharma AD - Key Employees
Sopharma AD - Key Employee Biographies
Sopharma AD - Major Products and Services
Sopharma AD - History
Sopharma AD - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Sopharma AD - Business Description
Sopharma AD - SWOT Analysis
SWOT Analysis - Overview
Sopharma AD - Strengths
Sopharma AD - Weaknesses
Sopharma AD - Opportunities
Sopharma AD - Threats
Sopharma AD - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sopharma AD, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 26, 2017: Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sopharma AD, Key Facts
Sopharma AD, Key Employees
Sopharma AD, Key Employee Biographies
Sopharma AD, Major Products and Services
Sopharma AD, History
Sopharma AD, Subsidiaries
Sopharma AD, Joint Venture
Sopharma AD, Key Competitors
Sopharma AD, Ratios based on current share price
Sopharma AD, Annual Ratios
Sopharma AD, Annual Ratios (Cont...1)
Sopharma AD, Annual Ratios (Cont...2)
Sopharma AD, Interim Ratios
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sopharma AD, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sopharma AD, Performance Chart (2013 - 2017)
Sopharma AD, Ratio Charts
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report